Sulforaphane - A possible agent in prevention and therapy of cancer;Sulforafan - Potencjalny czynnik w prewencji i terapii chorób nowotworowych

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 64, Issue , 2010, Pages 590-603

  Tomczyk, Joanna ^a   Olejnik, Anna ^a  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Bioavailability; Cancer chemoprevention; Metabolism; Sulforaphane

Indexed keywords

ANTINEOPLASTIC AGENT; SULFORAFAN; THIOCYANIC ACID DERIVATIVE;

HUMAN; NEOPLASM; REVIEW;

ANTICARCINOGENIC AGENTS; HUMANS; NEOPLASMS; THIOCYANATES;

EID: 79952723845     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Ambrosone C. B., McCann S. E., Freudenheim J. L., Marshall J. R., Zhang Y., Shields P. G.: Breast cancer risk in premenopausal women in inversely associated with consumption of broccoli, a source of isothiocyanates, but is modified by GST genotype. J. Nutr., 2004;134:1134-1138 (Pubitemid 38619952)
2. Asakage M., Tsuno N. T., Kitayama J., Tsuchiya T., Yoneyama S., Yamada J., Okaji Y., Kaisaki S., Osada T., Takahashi K., Nagawa H.: Sulforaphane induces inhibition of human umbilical vein endothelial cells proliferation by apoptosis. Angiogenesis, 2006;9:83-91 (Pubitemid 44440553)
3. Bacon J. R., Williamson G., Garner R. C., Lappin G., Langouet S., Bao Y.: Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepatocytes. Carcinogenesis, 2003;24:1903-1911 (Pubitemid 38008530)
4. Banning A., Brigelius-Flohe R.: NF-kappaB, Nrf2, and HO-1 interplay in redox-regulated VCAM-1 expression. Antioxid. Redox. Signal., 2005;7:889-899 (Pubitemid 40967140)
5. Barcelo S., Gardiner J. M., Gescher A., Chipman J. K.: CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis, 1996;17:277-282 (Pubitemid 26091306)
6. Basten G. P., Bao Y., Williamson G.: Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells. Carcinogenesis, 2002;23:1399-1404
7. Bertl E., Bartsch H., Gerhauser C: Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. Mol. Cancer Ther., 2006;5:575-585
8. Bheemreddy R. M., Jeffery E. H.: The metabolic fate of purified glucoraphanin in F344 rats. J. Agric. Food Chem., 2007;55:2861-2866 (Pubitemid 46668290)
9. Bonnesen C, Eggleston I. M., Hayes J. D.: Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res., 2001;61:6120-6130 (Pubitemid 32762548)
10. Brooks J. D., Paton V. G., Vidanes G.: Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol. Biomarkers Prev., 2001;10:949-954 (Pubitemid 32844902)
11. Cheung K. L., Khor T. O., Kong A. N.: Synergistic effect of combination of phenethyl isothiocyanate and sulforaphane or curcumin and sulforaphane in the inhibition of inflammation. Pharmaceut. Res., 2009;26:224-231
12. Chiao J. W., Chung F. L., Kancherla R., Ahmed T., Mittelman A., Conaway C. C.: Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int. J. Oncol., 2002;20:631-636
13. Cho S. D., Li G., Hu H., Jiang C, Kang K. S., Lee Y. S, Kim S. H., Lu J.: Involvement of c-jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU 145 prostate cancer cells. Nutr. Cancer, 2005;52:213-224 (Pubitemid 41579763)
14. Choi S., Lew K. L., Xiao H., Herman-Antosiewicz A., Xiao D., Brown C. K., Singh S. V.: D, L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Carcinogenesis, 2007;28:151-162 (Pubitemid 44942639)
15. Chu F. F., Esworthy R. S., Doroshow J. H.: Role of Se-dependent glutathione peroxidases in gastrointestinal inflammation and cancer. Free Radic. Biol. Med., 2004;36:1481-1495 (Pubitemid 38746557)
16. Chung F. L., Conaway C. C., Rao C. V., Reddy B. S.: Chemoprevention of colonic aberrant crypt foci in Fisher rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis, 2000;21:2287-2291 (Pubitemid 32049237)
17. Conaway C. C., Getahun S. M., Liebes L. L., Pusateri D. J., Topham D. K., Botero-Omary M., Chung F. L.: Disposition of glucosinolates and sulforaphane in humans after ingestion of steamed and fresh broccoli. Nutr. Cancer, 2000;38:168-178 (Pubitemid 32762016)
18. Cornblatt B. S., Ye L., Dinkova-Kostova A. T., Erb M., Fahey J. W., Singh N. K., Chen M. S., Stierer T., Garrett-Mayer E., Argani P., Davidson N. E., Talalay P., Kensler T. W., Visvanathan K.: Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis, 2007;28:1485-1490 (Pubitemid 47241798)
19. Dietrich C. G., Ottenhoff R., de Waart D. R., OudeElferink R. P.: Role of MRP2 and GSH in intrahepatic cycling of toxins. Toxicology, 2001;167:73-81 (Pubitemid 32830948)
20. Dinkova-Kostova A. T., Holtzclaw W. D., Cole R. N., Itoh K., Wakabayashi N., Katoh Y.: Direct evidence that sulfhydyl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and antioxidants. Proc. Natl. Acad. Sci. USA, 2002;99:11908-11913 (Pubitemid 34994497)
21. Fahey J. W., Haristoy X., Dolan P. M., Kensler T. W., Scholtus I., Stephenson K. K., Talalay P., Lozniewski A.: Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene induced stomach tumors. Proc. Natl. Acad. Sci. USA, 2002;99:7610-7615 (Pubitemid 34568739)
22. Fimognari C, Berti F., Cantelli-Forti G., Hrelia P.: Effect of sulforaphane on micronucleus induction in cultured human lymphocytes by four different mutagens. Environ. Mol. Mutagen., 2005;46:260-267 (Pubitemid 43107947)
23. Fimognari C, Lenzi M., Cantelli-Forti G., Hrelia P.: Induction of differentiation in human promyelocytic cells by the isothiocyanate sulforaphane. In Vivo, 2008;22:317-320 (Pubitemid 351890808)
24. Fimognari C, Lenzi M., Sciuscio D., Cantelli-Forti G., Hrelia P.: Cell-cycle specificity of sulforaphane-mediated apoptosis in Jurkat T-leukemia cells. In Vivo, 2007;21:377-380 (Pubitemid 46534294)
25. Fimognari C, Nusse M., Cesari R., Iori R., Cantelli-Forti G., Hrelia P.: Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane, Carcinogenesis, 2002;23:581-586 (Pubitemid 34498494)
26. Fowke J. H., Chung FL, Jin E., Qi D., Cai Q., Conaway C, Cheng J. R., Shu X. O., Gao Y. T., Zheng W.: Urinary isothiocyanate levels, brassica, and human breast cancer. Cancer Res., 2003;63:3980-3986 (Pubitemid 36917915)
27. Gamet-Payrastre L., Li P., Lumeau S., Cassar G., Dupont M. A, Chevolleau S., Gasc N., Tulliez J., Terce F.: Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res., 2000;60:1426-1433 (Pubitemid 30152017)
28. Gamet-Payrastre L., Lumeau S., Gasc N., Cassar G., Rollin P., Tulliez J.: Selective cytostatic and cytotoxic effects of glucosinolates hydrolysis products on human colon cancer cells in vitro. Anticancer Drugs, 1998;9:141-148 (Pubitemid 28080635)
29. Garrett M. D.: Cell cycle control and cancer. Current Science, 2001;5:515-522 (Pubitemid 33616371)
30. Gasper A. V., Al-Janobi A., Smith J. A., Bacon J. R., Fortun P., Atherton C, Taylor M. A., Hawkey C. J., Barrett DA., Mithen R. F.: Glutathione s-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am. J. Clin. Nutr., 2005;82:1283-1291 (Pubitemid 43779728)
31. Gingras D., Gendron M., Boivin D., Moghrabi A., Theoret Y, Beliveau R.: Induction of medulloblastoma cell apoptosis by sulforaphane, a dietary anticarcinogen from Brassica vegetables. Cancer Lett., 2004;203:35-43 (Pubitemid 37506081)
32. Giovannucci E., Rimm E. B., Liu Y, Stampfer M. J., Willet W. C: A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol BiomarkersPrev., 2003;12:1403-1409 (Pubitemid 38031741)
33. Hakama M.: Chemoprevention of cancer. Acta Oncol, 1998;37:227-230 (Pubitemid 28307844)
34. Haristoy X., Angioi-Duprez K., Duprez A., Lozniewski A.: Efficacy of sulforaphane in eradicating Helicobacter pylori in human gastric xenografts implanted in nude mice. Antimicrob. Agents Chemother., 2003;47:3982-3984 (Pubitemid 37485022)
35. Hecht S. S.: Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. J. Nutr., 1999;129:768S-774S
36. Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhauser C: Nuclear factor kappa B is a molecular target for sulforaphane-mediated antiinflammatory mechanisms. J. Biol. Chem., 2001;276:32008-32015
37. Herman-Antosiewicz A., Xiao H., Lew K. L., Singh S. V: Induction of p21 protein protects against sulforaphane induced mitotic arrest in LnCaP human prostate cancer cell line. Mol. Cancer Ther., 2007;6:1673-1681 (Pubitemid 46954034)
38. Hu R., Hebbar V., Kim B. R., Chen C, Winnik B., Buckley B., Soteropoulos P., Tolias P., Hart R. P., Kong A. N.: In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J. Pharmacol. Exp. Ther., 2004;310:263-271 (Pubitemid 38812720)
39. Hu R., Khor T. O., Shen G., Jeong W. S., Hebbar V, Chen C, Xu C, Reddy B., Chada K., Kong A. N: Cancer chemoprevention of intestinal polyposis in Apc min/+ mice by sulforaphane, a natural product derived from cruciferous vegetable. Carcinogenesis, 2006;27:2038-2046 (Pubitemid 44530579)
40. Jackson S. J., Singletary K. W.: Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. J. Nutr., 2004;134:2229-2236 (Pubitemid 39201590)
41. Jackson S. J., Singletary K. W.: Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis, 2004;25:219-227 (Pubitemid 38239805)
42. Jakubikova J., Bao Y., Sedlak J.: Isothiocyanates induce cell cycle arrest, apoptosis and mitochondrial potential depolarization in HL-60 and multidrug-resistant cell lines. Anticancer Res., 2005;25:3375-3386 (Pubitemid 41105214)
43. Jakubikova J., Sedlak J., Mithen R., Bao Y.: Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane and erucin induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells. Biochem. Pharmacol., 2005;69:1543-1552 (Pubitemid 40719490)
44. Jiang H., Shang X., Wu H., Huang G., Wang Y., Al-Holou S., Gautam S. C., Chopp M.: Combination treatment with resveratrol and sulforaphane Induces apoptosis in human U251 glioma cells. Neurochem. Res., 2010;35:152-161
45. Jiang Z. Q., Chen C, Yang B., Hebbar V, Kong A. N.: Differential responses from seven mammalian cell lines to the treatments of detoxifying enzyme inducers. Life Sci., 2003;72:2243-2253 (Pubitemid 36287361)
46. Jones S. B., Brooks J. D.: Modest induction of phase 2 enzyme activity in the F344 rat prostate. BMC Cancer, 2006;6:62-70
47. Joseph MA., Moysich K. B., Freudenheim J. L., Shields P. G., Bowman E. D., Zhang Y., Marshall J. R., Ambrosone C. B.: Cruciferous genetic polymorphisms in glutatione S-transferases M1 and T1, and prostate cancer risk. Nutr. Cancer, 2004;50:206-213
48. Karmakar S., Weinberg M. S., Banik N. L., Patel S. J., Ray S. K.: Activation of multiple molecular mechanisms for apoptosis in human malignant glioblastoma T98G and U87MG cells treated with sulforaphane. Neuroscience, 2006;141:1265-1280 (Pubitemid 44128679)
49. Kassahun M., Davis M., Hu P., Martin B., Baillie T: Biotransformation of the naturally occurring isothiocyanate sulforaphane in the rat: identification of phase I metabolites and glutathione conjugates. Chem. Res. Toxicol., 1997;10:1228-1233 (Pubitemid 27524827)
50. Kassie F., Rabot S., Uhl M., Huber W., Qin H. M., Helma C, Schulte-Hermann R., Knasmuller S.: Chemoprotective of garden cress (Lepidium sativum) and its constituents towards 2-amino-3-methyl-imidazo[4, - 5-f]quinoline (IQ)-induced genotoxic effects and colonic preneoplastic lesions. Carcinogenesis, 2002;23:1155-1161 (Pubitemid 34814773)
51. Kassie F., Uhl M., Rabot S., Grasl-Kraupp B., Verkerk R., Kundi M., Chabicovsky M., Schulte-Hermann R., Knasmuller S.: Chemoprevention of 2-amino-3-methyl-imidazo[4, 5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in F344 rat by cruciferous vegetables administered simultanously with the carcinogen. Carcinogenesis, 2003;24:255-261 (Pubitemid 36267094)
52. Keck A. S., Qiao Q., Jeffery E. H.: Food matrix effects on bioactivity of broccoli-derived sulforaphane in liver and colon of F344 rats. J. Agric. Food Chem., 2003;51:3320-3327
53. Killeen M. E., Englert J. A., Stolz D. B., Song M., Han Y., Delude R. L., Kellum J. A., Fink M. P.: The phase 2 enzyme inducers ethacrynic acid, DL-sulforaphane, and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cells. J. Pharmacol. Exp. Ther., 2006;316:1070-1079 (Pubitemid 43345280)
54. Kim E., Kim E. H., Eom Y. W., Kim W. H., Kwon K. W., Lee S. J., Choi K. S.: Sulforaphane sensitizes tumor necrosis factor related apoptosisinducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Cancer Res., 2006;66:1740-1750 (Pubitemid 43259959)
55. Kuroiwa Y., Nishikawa A., Kitamura Y., Kanki K., Ishii Y., Umemura T., Hirose M.: Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters. Cancer Lett., 2006;241:275-280 (Pubitemid 44163037)
56. Kushad M. M, Brown A. F., Kurilich A. C., Juvik J. A., Wallig M. A., Jeffery E. H.: Variation of glucosinolates in vegetable crops of Brassica oleracea. J. Agric. Food Chem., 1997;47:1541-1548
57. Lampe J. W., Peterson S.: Brassica, biotransformation and cancer risk: genetic polymorphisms alter the preventive effects of cruciferous vegetables. J. Nutr., 2002;132:2991-2994
58. Liang H., Yuan Q. P., Dong H. R., Liu Y. M.: Determination of sulforaphane in broccoli and cabbage by high-performance liquid chromatography. J. Food Comp. Anal., 2006;19:473-476
59. Lin H. J., Probst-Hensch N. M., Louie A. D, Kau I. H., Witte J. S., Ingles S. A., Frankl H. D., Lee E. R., Haile R.: Glutathione transferase null genotype, broccoli, and lover prevalence of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev., 1998;7:647-652 (Pubitemid 28374593)
60. Lin W., Wu R. T., Wu T., Khor T. O., Wang H., Kong A. N.: Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem. Pharmacol, 2008;76:967-973
61. London S. J., Yuan J. M., Chung F. L., Gao Y. T., Coetzee G. A., Ross R. K., Yu M. C.: Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet, 2000;356:724-729 (Pubitemid 30663242)
62. Maheo K., Morel F., Langouet S., Kramer H., Le Ferrec E., Ketterer B., Guillouzo A.: Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res., 1997;57:3649-3652 (Pubitemid 27381200)
63. McWalter G. K., Higgins L. G., McLellan L. I., Henderson C. J., Song L., Thornalley P. J., Itoh K., Yamamoto M., Hayes J. D.: Transcription factor nrf2 is essential for induction of NAD (P) H:quinone oxidoreductase 1, glutathione S-transferases, and glutamate cysteine ligase by broccoli seeds and isothiocyanates. J. Nutr., 2004;134:3499-3506
64. Mithen R., Faulkner K., Magrath R, Rose P., Williamson G., Marquez J.: Development of isothiocyanate-enriched broccoli, and its enhanced ability to induce phase 2 detoxification enzymes in mammalian cells. Theor. Appl. Genet., 2003;106:727-734 (Pubitemid 36599842)
65. Myzak M. C., Dashwood R. H.: Chemoprotection by sulforaphane: Keep one eye beyond Keap1. Cancer Lett., 2006;233:208-218 (Pubitemid 43327375)
66. Myzak M. C., Dashwood W. M., Orner G. A., Ho E., Dashwood R. H.: Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J., 2006;20:506-508 (Pubitemid 46671231)
67. Myzak M. C., Hardin K., Wang R., Dashwood R. H., Ho E.: Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis, 2006;27:811-819
68. Myzak M. C., Karplus P. A., Chung, F. L., Dashwood R. H.: A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res., 2004;64:5767-5774 (Pubitemid 39095576)
69. Myzak M. C., Tong P., Dashwood W. M., Dashwood R. H., Ho E.: Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp. Biol. Med. (Maywood), 2007;232:227-234 (Pubitemid 46203291)
70. Pappa G., Bartsch H., Gerhauser C: Biphasic modulation of cell proliferation by sulforaphane at physiologically relevant exposure times in a human colon cancer cell line. Mol. Nutr. Food Res., 2007;51:977-984 (Pubitemid 47292272)
71. Pappa G., Lichtenberg M., Iori R., Barillari J., Bartsch H., Gerhauser C: Comparison of growth inhibition profiles and mechanisms of apoptosis induction in human colon cancer cell lines by isothiocyanates and indoles from Brassicaceae. Mutation Res., 2006;599:76-87 (Pubitemid 44041504)
72. Park S. Y., Kim G. Y., Bae S. J., Yoo Y. H., Choi Y. H.: Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. Oncol. Rep., 2007;18:181-187
73. Parnaud G., Li P., Cassar G., Rouimi P., Tulliez J., Combaret L., Gamet-Payrastre L.: Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr. Cancer, 2004;48:198-206 (Pubitemid 39045782)
74. Petri N., Tannergren C, Holst B., Mellon F. A., Bao Y., Plumb G. W., Bacon J., O'Leary K. A., Kroon P. A., Knutson L., Forsell P., Eriksson T., Lennernas H., Williamson G.: Absorption/metabolism of sulforaphane and quercetin, and regulation of phase ii enzymes, in human jejunum in vivo. Drug Metab. Dispos., 2003;31:805-813 (Pubitemid 36617672)
75. Pham N. A., Jacobberger J. W., Schimmer A. D., Cao P., Gronda M., Hedley D. W.: The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodefcient mice. Mol. Cancer Ther., 2004;3:1239-1248 (Pubitemid 39440169)
76. Rose P., Huang Q., Ong C. N., Whiteman M.: Broccoli and watercress suppress matrix metalloproteinase-9 activity and invasiveness of human MDA-MB-231 breast cancer cells. Toxicol. Appl. Pharmacol., 2005;209:105-113 (Pubitemid 41587401)
77. Rudolf E., Andelova H., Cervinka M.: Activation of several concurrent proapoptic pathways by sulforaphane in human colon cancer cells SW620. Food Chem. Toxicol., 2009;47:2366-2373
78. Seligson D. B., Horvath S., Shi T., Yu H., Tze S., Grunstein M., Kurdistani S. K.: Global histone modification patterns predict risk of prostate cancer recurrence. Nature, 2005;435:1262-1266 (Pubitemid 40943093)
79. Seow A., Shi C. Y., Chung F. L., Jiao D., Hankin J. H, Lee H. P, Coetzee G. A., Yu M. C.: Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes. Cancer Epidemiol. Biomarkers Prev., 1998;7:775-781 (Pubitemid 28420615)
80. Seow A., Vainio H., Yu M. C.: Effect of glutathione-stransferase polymorphisms on the cancer preventive potential of isothiocyanates: an epidemiological perspective. Mutat. Res., 2005;592:58-67 (Pubitemid 41714044)
81. Seow A., Yuan J. M., Sun C. L., Van Den Berg D., Lee H. P, Yu M. C: Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinogenesis, 2002;23:2055-2061 (Pubitemid 36104958)
82. Shapiro T. A., Fahey J. W., Wade K. L., Stephenson K. K., Talalay P.: Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol. Biomarkers Prev., 1998;7:1091-1100 (Pubitemid 29001665)
83. Shen G., Xu C, Chen C, Hebbar V, Kong A. N.: p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Chemother. Pharmacol., 2006;57:317-327
84. Singh A. V, Xiao D., Lew K. L., Dhir R., Singh S. V: Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis, 2004;25:83-90 (Pubitemid 38128621)
85. Singh S. V, Herman-Antosiewicz A., Singh A. V, Lew K. L., Srivastava S. K., Kamath R., Brown K. D., Zhang L., Baskaran R.: Sulforaphaneinduced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J. Biol. Chem., 2004;279:25813-25822 (Pubitemid 38756846)
86. Singh S. V, Srivastava S. K., Choi S., Lew K. L., Antosiewicz J., Xiao D., Zeng Y., Watkins S. C., Johnson C. S., Trump D. L., Lee Y. J., Xiao H., Herman-Antosiewicz A.: Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J. Biol. Chem., 2005;280:19911-19924 (Pubitemid 41379520)
87. Singletary K., MacDonald C: Inhibition of benzo[a]pyrene and 1, 6-dinitropyrene-DNA adduct formation in human mammary epithelial cells by dibenzoylmethane and sulforaphane. Cancer Lett., 2000;155:47-54 (Pubitemid 30256223)
88. Spitz M. R., Duphorne CM., Detry M. A., Pillow P. C., Amos C. I., Lei L., de Andrade M., Gu X., Hong W. K., Wu X.: Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 2000;9:1017-1020
89. Svehlikova V, Wang S., Jakubikova J., Williamson G., Mithen R., Bao Y.: Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in Caco-2 cells. Carcinogenesis, 2004;25:1629-1637 (Pubitemid 39214305)
90. Thejass P., Kuttan G.: Antimetastatic activity of sulforaphane. Life Sci., 2006;78:3043-3050
91. Thimmulappa R. K., Mai K. H., Srisuma S., Kensler T. W., Yamamoto M., Biswal S.: Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res., 2005;62:5196-5203
92. Wang L., Liu D., Ahmed T., Chung F. L., Conaway C, Chiao J. W.: Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int. J. Oncol., 2004;24:187-192
93. Wang L. I., Giovannucci E. L., Hunter D., Neuberg D., Su L., Christiani D. C: Dietary intake of cruciferous vegetables, glutathione S-transferase (GST) polymorphisms and lung cancer risk in Caucasian population. Cancer Causes Control, 2004;15:977-985 (Pubitemid 41449278)
94. Wideł M. S., Wideł M.: Mechanizmy przerzutowania i molekularne markery progresji nowotworów złośliwych. I. Rak jelita grubego. Postȩpy Hig. Med. Dosw., 2006;60:453-470
95. Winiwarter S., Bonham N. M., Ax F., Hallberg A., Lennernas H., Karlen A.: Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J. Med. Chem., 1998;41:4939-4949 (Pubitemid 28555452)
96. Woessner J. F. Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J., 1991;5:2145-2154 (Pubitemid 21905847)
97. Xu C, Shen G., Yuan X., Kim J. H., Gopalkrishnan A., Keum Y. S.: ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis, 2006;27:437-445 (Pubitemid 43372873)
98. Yang C. S., Smith T. J., Hong J. Y.: Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations. Cancer Res., 1994;54:1982s-1986s (Pubitemid 24132160)
99. Ye L., Dinkova-Kostova A. T., Wade K. L., Zhang Y., Shapiro T. A., Talalay P.: Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clin. Chim. Acta, 2002;316:43-53 (Pubitemid 34028187)
100. Yeh C. T., Yen G. C.: Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells. Carcinogenesis, 2005;26:2138-2148
101. Zhang Y.: Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action. Mutation Res., 2004;555:173-190 (Pubitemid 39345403)
102. Zhang Y, Callaway E. C.: High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. Biochem. J., 2002;364:301-307 (Pubitemid 34538974)
103. Zhang Y., Talalay P., Cho G. C., Posner G. H.: A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. USA, 1992;89:2399-2403
104. Zhu P., Martin E., Mengwasser J., Schlag P., Janssen K. P, Gottlicher M.: Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell, 2004;5:455-463 (Pubitemid 38610247)